B. G�ke

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

Andreas Helisch, GregorJ. F�rster, Helmut Reber et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2004 · 130 citations

Medicine, Nuclear Medicine, Pharmacokinetics +14

Cloning and quantitative determination of the human Ca 2+ /calmodulin-dependent protein kinase II (CaMK II) isoforms in human beta cells

H. Rochlitz, Antje Voigt, Brigitte Lankat–Buttgereit et al. · Diabetologia · 2000 · 27 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study

R. Eissele, R�diger G�ke, Ulrike Weichardt et al. · Cell and Tissue Research · 1994 · 14 citations

Medicine, Endocrinology, Oncology +16

Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (?TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells

H. C. Fehmann, Michael Jan�en, B. G�ke · Acta Diabetologica · 1995 · 12 citations

Life Sciences, Cell Biology, Endocrinology +12

Glucagon-like-peptide-1 (7?36) amide improves glucose sensitivity in beta-cells of NOD mice

Thomas Linn, K. Schneider, B. G�ke et al. · Acta Diabetologica · 1996 · 12 citations

Life Sciences, Biochemistry, Endocrinology +13